UBS Group’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-867
Closed -$3.49K 10473
2024
Q1
$3.49K Buy
+867
New +$3.33K ﹤0.01% 7738
2023
Q4
Sell
-1,917
Closed -$4.67K 10497
2023
Q3
$4.67K Buy
+1,917
New +$5.2K ﹤0.01% 7424
2023
Q2
Sell
-443
Closed -$1.4K 10131
2023
Q1
$1.4K Buy
443
+113
+34% +$362 ﹤0.01% 8750
2022
Q4
$1.11K Buy
+330
New +$907 ﹤0.01% 9953
2022
Q2
Sell
-315
Closed -$2K 11303
2022
Q1
$2K Buy
315
+289
+1,112% +$3.16K ﹤0.01% 9734
2021
Q4
$0 Sell
26
-656
-96% -$21.7K ﹤0.01% 10970
2021
Q3
$28K Buy
682
+94
+16% +$4.33K ﹤0.01% 6835
2021
Q2
$36K Buy
588
+31
+6% +$1.91K ﹤0.01% 6756
2021
Q1
$36K Buy
+557
New +$38.2K ﹤0.01% 6864
2020
Q3
Sell
-166
Closed -$6K 8559
2020
Q2
$6K Buy
+166
New +$6.73K ﹤0.01% 7325

UBS Group's GTH Position: Q2 2024 in Review

UBS Group sold out of Genetron Holdings Limited ADS (GTH) in Q2 2024, closing a stake of 867 shares — an estimated $3.49K sold.

UBS Group first reported a position in GTH in Q2 2020 and held it in 10 quarters. The position peaked at $36K in Q2 2021. 0 funds tracked by Wall St. Rank hold GTH as of Q2 2024.

  • UBS Group reported no remaining Genetron Holdings Limited ADS position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 867 Genetron Holdings Limited ADS shares in Q2 2024, an estimated $3.49K.
  • UBS Group first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 10 quarters.
  • UBS Group's Genetron Holdings Limited ADS position peaked at $36K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.